The health service is rolling out an injectable form of immunotherapy, nivolumab, which means patients can receive their fortnightly or monthly treatment in 5 minutes instead of up to an hour via an IV drip.
The roll-out will save over a year’s worth of treatment time for patients and NHS teams annually – enabling patients to spend less time in hospital while freeing up staff capacity to deliver more appointments and treatments.
The new jab can be used to treat 15 cancer types, including skin cancer, bladder, and oesophagus, and it is estimated around 1,200 patients in England per month could benefit…
